Cubicin

In the US, Cubicin (daptomycin systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Endocarditis, Methicillin-Resistant Staphylococcus Aureus Infection, Skin and Structure Infection and Skin Infection.

US matches:

• Cubicin

UK matches:

• CUBICIN 350 mg powder for concentrate for solution for injection or infusion
• Cubicin 500 mg powder for concentrate for solution for injection or infusion
• Cubicin powder for concentrate for solution for injection or infusion (SPC)

Ingredient matches for Cubicin

Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Cubicin in the following countries:

• Ireland

Daptomycin

Daptomycin is reported as an ingredient of Cubicin in the following countries:

• Australia


• Austria


• Canada


• Croatia (Hrvatska)


• Denmark


• Finland


• France


• Germany


• Italy


• Luxembourg


• Netherlands


• Norway


• Portugal


• Slovenia


• Spain


• Sweden


• Switzerland


• Taiwan


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.